EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Metformin and nephroprotection in Autosomal Dominant Polycystic Kidney Disease: preclinical evidence and preliminary results from the METROPOLIS trial

Giovanni Piscopo

Giornale di Clinica Nefrologica e Dialisi · 31.12.2025 · 37 (Suppl.1) · 17-18

DOI: 10.33393/gcnd.2025.3744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Giornale di Clinica Nefrologica e Dialisi, online erschienen am 31.12.2025. Verfasst von Giovanni Piscopo. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

FIGURA 1 -Incidenza di almeno un evento avverso e incidenza di diarrea.FIGURA 2 -Confronto eGFR su scala logaritmica a 12 mesi e a 24 mesi.

Zitieren

APA

Piscopo, G. (2025). Metformin and nephroprotection in Autosomal Dominant Polycystic Kidney Disease: preclinical evidence and preliminary results from the METROPOLIS trial. Giornale di Clinica Nefrologica e Dialisi, 37(Suppl.1), 17-18. https://doi.org/10.33393/gcnd.2025.3744

Vancouver

Piscopo G. Metformin and nephroprotection in Autosomal Dominant Polycystic Kidney Disease: preclinical evidence and preliminary results from the METROPOLIS trial. Giornale di Clinica Nefrologica e Dialisi. 2025;37(Suppl.1):17-18. doi:10.33393/gcnd.2025.3744

BibTeX
@article{Piscopo2025,
  author = {Piscopo, Giovanni},
  title = {Metformin and nephroprotection in Autosomal Dominant Polycystic Kidney Disease: preclinical evidence and preliminary results from the METROPOLIS trial},
  journal = {Giornale di Clinica Nefrologica e Dialisi},
  year = {2025},
  volume = {37},
  number = {Suppl.1},
  pages = {17--18},
  doi = {10.33393/gcnd.2025.3744}
}
Kostenlos starten →